{{Rsnum
|rsid=6741819
|Gene=RNF144A
|Chromosome=2
|position=7007842
|Orientation=plus
|GMAF=0.2544
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RNF144A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 43.4 | 8.0
| HCB | 86.1 | 13.9 | 0.0
| JPT | 93.8 | 6.2 | 0.0
| YRI | 44.9 | 40.1 | 15.0
| ASW | 42.1 | 54.4 | 3.5
| CHB | 86.1 | 13.9 | 0.0
| CHD | 89.9 | 9.2 | 0.9
| GIH | 82.2 | 15.8 | 2.0
| LWK | 34.5 | 51.8 | 13.6
| MEX | 67.2 | 25.9 | 6.9
| MKK | 29.5 | 46.8 | 23.7
| TSI | 54.9 | 39.2 | 5.9
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 2 x 10^-7 for triglycerides as a result of [[perphenazine]] use

{{on chip | Affy GenomeWide 6}}